2016 Archived Content

Additional Opportunities to Learn & Collaborate


Dinner Course - Meeting the Customers’ Needs. What Are the Expectations of Risk-Based Monitoring?


What’s New in 2016

A Fresh Focus on Vendor Performance and Quality

Dedicated Programming for Small and Mid-Sized Pharma/Biotech

Lessons Learned on Risk-Based Monitoring from Companies Further Ahead in Implementing RBM

Discussion of New and Emerging Tech across Pharma for Clinical Trials

In-Depth Coverage of Secondary Data Use, Data Sharing and Data Privacy

Featured Presenters

Jacobs SherylSheryl Jacobs
Vice President, Global Study Operations, Amgen


LITTLE JANISJanis Little
Vice President, Global R&D Quality, Allergan


Anita ZubakAnita Zubak
Executive Director, Global Clinical Trial Operations IT, Merck


Rosenfeld MarieMarie Rosenfeld
Director, Development Operations, Contracts & Outsourcing Vendor Management Lead, Astellas


Nickerson DavidDavid Nickerson
Senior Director, Portfolio & Vendor Quality, Pfizer


Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag


From the Producers of:

From the Producers of SCOPE